A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus

Background. Sevoflurane is rarely used for the treatment of status asthmaticus. We report a case of sevoflurane hepatotoxicity in pregnancy with presentation similar to HELLP syndrome. Case. A G2P1001 at 23 weeks in status asthmaticus presented with pCO2 > 130 and pH < 7. She was nonresponsive...

Full description

Saved in:
Bibliographic Details
Main Authors: Jessica Parrott, Mitch Tener, Katie Dennis, Matthew Sharpe, Cecily Clark-Ganheart
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2017/3547242
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566874984939520
author Jessica Parrott
Mitch Tener
Katie Dennis
Matthew Sharpe
Cecily Clark-Ganheart
author_facet Jessica Parrott
Mitch Tener
Katie Dennis
Matthew Sharpe
Cecily Clark-Ganheart
author_sort Jessica Parrott
collection DOAJ
description Background. Sevoflurane is rarely used for the treatment of status asthmaticus. We report a case of sevoflurane hepatotoxicity in pregnancy with presentation similar to HELLP syndrome. Case. A G2P1001 at 23 weeks in status asthmaticus presented with pCO2 > 130 and pH < 7. She was nonresponsive to traditional therapy. Sevoflurane was added for a 24 hr period. Respiratory status improved. Extubation occurred on day 12. Workup for preeclampsia spectrum disorders occurred due to maternal hypertension. Given the atypical presentation and hepatotoxicity, a liver biopsy was performed. Histologic features suggested drug induced hepatic injury. Liver function subsequently normalized. She delivered a term neonate without short-term complications. Conclusion. The use of sevoflurane is a treatment option of status asthmaticus during pregnancy. Providers should be aware of the potential for hepatotoxicity.
format Article
id doaj-art-0297f2d3c6914c5b8a589b912a65bd9e
institution Kabale University
issn 2090-6684
2090-6692
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Obstetrics and Gynecology
spelling doaj-art-0297f2d3c6914c5b8a589b912a65bd9e2025-02-03T01:02:55ZengWileyCase Reports in Obstetrics and Gynecology2090-66842090-66922017-01-01201710.1155/2017/35472423547242A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status AsthmaticusJessica Parrott0Mitch Tener1Katie Dennis2Matthew Sharpe3Cecily Clark-Ganheart4Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USADepartment of Pulmonary and Critical Care Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USADepartment of Pathology and Laboratory Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USADepartment of Pulmonary and Critical Care Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USADivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USABackground. Sevoflurane is rarely used for the treatment of status asthmaticus. We report a case of sevoflurane hepatotoxicity in pregnancy with presentation similar to HELLP syndrome. Case. A G2P1001 at 23 weeks in status asthmaticus presented with pCO2 > 130 and pH < 7. She was nonresponsive to traditional therapy. Sevoflurane was added for a 24 hr period. Respiratory status improved. Extubation occurred on day 12. Workup for preeclampsia spectrum disorders occurred due to maternal hypertension. Given the atypical presentation and hepatotoxicity, a liver biopsy was performed. Histologic features suggested drug induced hepatic injury. Liver function subsequently normalized. She delivered a term neonate without short-term complications. Conclusion. The use of sevoflurane is a treatment option of status asthmaticus during pregnancy. Providers should be aware of the potential for hepatotoxicity.http://dx.doi.org/10.1155/2017/3547242
spellingShingle Jessica Parrott
Mitch Tener
Katie Dennis
Matthew Sharpe
Cecily Clark-Ganheart
A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus
Case Reports in Obstetrics and Gynecology
title A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus
title_full A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus
title_fullStr A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus
title_full_unstemmed A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus
title_short A Case of Sevoflurane Use during Pregnancy in the Management of Persistent Status Asthmaticus
title_sort case of sevoflurane use during pregnancy in the management of persistent status asthmaticus
url http://dx.doi.org/10.1155/2017/3547242
work_keys_str_mv AT jessicaparrott acaseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT mitchtener acaseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT katiedennis acaseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT matthewsharpe acaseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT cecilyclarkganheart acaseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT jessicaparrott caseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT mitchtener caseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT katiedennis caseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT matthewsharpe caseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus
AT cecilyclarkganheart caseofsevofluraneuseduringpregnancyinthemanagementofpersistentstatusasthmaticus